fda warning letters compounded semaglutide tirzepatide 2025 Troubling Findings in Study of GLP-1 Compounders FDA Sends Warning Letters to

While the FDA label for oral semaglutide is the only one that mentions levothyroxine, a provider may want to monitor thyroid hormone levels for people with hypothyroidism who take any type of GLP-1

MK-677 may be more aggressively studied tool, but this does not make it the better tool of the two

Bioinformatics 29 , 1521 (2013)

Arzneimittel Forschung 1988

Tia Tackles Zepbound for Women: Weight Loss, Hormones, and Hidden Considerations Published: March 12, 2026 Updated: March 12, 2026 GLP-1 receptor agonists, the class of medications that includes semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have become some of the most talked-about drugs in modern medicine